Deal Watch: Lilly Continues Hectic Deal Stretch Via Renal-Focused Ascidian Collab Scrip Pharma Intelligence 21:49 Fri, 05 Jun
Eli Lilly continues genetic medicine push with $1.9bn Ascidian partnership Pharmaceutical Technology 11:57 Thu, 04 Jun
Lilly enters $1.9B kidney disease deal for Ascidian’s exon editors BioWorld 20:04 Wed, 03 Jun Article paywall
A weight-loss drug that also controls sleep apnea and knee pain: Eli Lilly may have found one Mint 08:06 Sun, 07 Jun Novo Nordisk Obesity Pharma All sources
Eli Lilly wins FDA nod for extended Ebglyss dosing in eczema care Zacks 6d Ebglyss FDA Pharma All sources
Lilly shares jump as analysts see retatrutide data extending obesity market edge BNN Bloomberg 8d Tirzepatide Obesity Pharma All sources
'A big step’: Colorado gets FDA OK to import cheaper drugs from Canada 7News Denver 4h FDA Colorado Jared Polis
Bayer extends partnership with Peking University to accelerate translation of scientific research and drive drug discovery and innovation Global Times 1d Bayer Chinese Economy China Politics
Johnson & Johnson pumping $1B into First Coast manufacturing facility Florida Politics 12h Johnson and Johnson Jacksonville Florida
Moderna CEO: ‘I worry deeply about bioterrorism’ euronews 1d Biotech Pharma Flotations/IPOs All sources
Pentagon adds 65 new entities to the 1260H list of Chinese military companies JD Supra 16h China Military Pentagon China All sources
GSK's Nuvalent deal tackles HIV cliff to win cautious backing from analysts Proactive Investors (US) 6d GSK Lung Cancer Pharma All sources
Heart drug developer Kardigan targets US$1.4 billion valuation in U.S. IPO BNN Bloomberg 5d Kardigan Biotech Flotations/IPOs All sources
Verastem Oncology to host Investor Conference Call and report updated data and progress across vs-7375 oral KRAS G12D (on/off) inhibitor target-d clinical program Business Wire (Press Release) 12h Biotechnology
STAT Plus: Trump’s obesity drug plan creates a temporary Medicare program that may be hard to end STAT 17h Obesity Diet and Fitness Pharma
Spruce Biosciences appoints Eric Jordan as Vice President, marketing and Tina gullotta as Vice President, Finance and corporate controller Business Wire (Press Release) 20h Banking Regulation California Business California Schools
